Alberta Investment Management Corp (AIMCo)’s Emergent Biosolutions EBS Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-94,200	Closed	-$458K	–	676
2025 Q1	$458K	Buy	+94,200	New	+$780K	﹤0.01%	685
2018 Q2	–	Sell	-22,500	Closed	-$1.19M	–	839
2018 Q1	$1.19M	Hold	22,500	–	–	0.01%	535
2017 Q4	$1.05M	Buy	22,500 +9,500	+73%	+$400K	0.01%	548
2017 Q3	$526K	Buy	+13,000	New	+$470K	﹤0.01%	645

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s EBS Position: Q2 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of Emergent Biosolutions (EBS) in Q2 2025, closing a stake of 94,200 shares — an estimated $458K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in EBS in Q3 2017 and held it in 4 quarters. The position peaked at $1.19M in Q1 2018. 161 funds tracked by Wall St. Rank hold EBS as of Q2 2025.

Alberta Investment Management Corp (AIMCo) reported no remaining Emergent Biosolutions position as of Q2 2025 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 94,200 Emergent Biosolutions shares in Q2 2025, an estimated $458K.
Alberta Investment Management Corp (AIMCo) first reported a position in Emergent Biosolutions in Q3 2017 and held it in 4 quarters.
Alberta Investment Management Corp (AIMCo)'s Emergent Biosolutions position peaked at $1.19M in Q1 2018.
161 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2025, filed 8 Aug 2025.